Sandra J. Hofstead

2.1k total citations
14 papers, 1.6k citations indexed

About

Sandra J. Hofstead is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Sandra J. Hofstead has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Sandra J. Hofstead's work include Peptidase Inhibition and Analysis (6 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). Sandra J. Hofstead is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). Sandra J. Hofstead collaborates with scholars based in United States, Germany and Switzerland. Sandra J. Hofstead's co-authors include Pamela A. Trail, Raymond A. Firestone, David Willner, Shirley J. Lasch, Gene M. Dubowchik, Anna Maria Casazza, Arris J. Henderson, Ingegerd Hellström, K E Hellström and Jay O. Knipe and has published in prestigious journals such as Science, Journal of the American Chemical Society and Analytical Biochemistry.

In The Last Decade

Sandra J. Hofstead

14 papers receiving 1.5k citations

Peers

Sandra J. Hofstead
David Willner United States
Thomas H. Pillow United States
Brian E. Toki United States
Nicole M. Okeley United States
Michael Torgov United States
Tim D. Bovee United States
Roger F. Zabinski United States
Wayne C. Widdison United States
Kyoji Tsuchikama United States
Sandra J. Hofstead
Citations per year, relative to Sandra J. Hofstead Sandra J. Hofstead (= 1×) peers Marion Gurrath

Countries citing papers authored by Sandra J. Hofstead

Since Specialization
Citations

This map shows the geographic impact of Sandra J. Hofstead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra J. Hofstead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra J. Hofstead more than expected).

Fields of papers citing papers by Sandra J. Hofstead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra J. Hofstead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra J. Hofstead. The network helps show where Sandra J. Hofstead may publish in the future.

Co-authorship network of co-authors of Sandra J. Hofstead

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra J. Hofstead. A scholar is included among the top collaborators of Sandra J. Hofstead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra J. Hofstead. Sandra J. Hofstead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Steele, Christopher L., Yijun Chen, Brian Dougherty, et al.. (2005). Purification, cloning, and functional expression of phenylalanine aminomutase: The first committed step in Taxol side-chain biosynthesis. Archives of Biochemistry and Biophysics. 438(1). 1–10. 42 indexed citations
2.
Zawadzke, Laura E., Ping Wu, Lynda Cook, et al.. (2003). Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention. Analytical Biochemistry. 314(2). 243–252. 44 indexed citations
3.
Walker, Michael, Gene M. Dubowchik, Sandra J. Hofstead, Pamela A. Trail, & Raymond A. Firestone. (2002). Synthesis of an immunoconjugate of camptothecin. Bioorganic & Medicinal Chemistry Letters. 12(2). 217–219. 33 indexed citations
4.
Dubowchik, Gene M., Harold Mastalerz, Michael Walker, et al.. (2002). Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages. Bioorganic & Medicinal Chemistry Letters. 12(11). 1529–1532. 30 indexed citations
5.
King, Dalton, Gene M. Dubowchik, Harold Mastalerz, et al.. (2002). Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers:  Inhibition of Aggregation by Methoxytriethyleneglycol Chains. Journal of Medicinal Chemistry. 45(19). 4336–4343. 100 indexed citations
6.
Dubowchik, Gene M., Raymond A. Firestone, David Willner, et al.. (2002). Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates:  Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity. Bioconjugate Chemistry. 13(4). 855–869. 396 indexed citations
7.
Trail, Pamela A., David Willner, Jay O. Knipe, et al.. (1997). Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.. PubMed. 57(1). 100–5. 45 indexed citations
8.
Firestone, Raymond A., David Willner, Sandra J. Hofstead, et al.. (1996). Synthesis and antitumor activity of the immunoconjugate BR96-Dox. Journal of Controlled Release. 39(2-3). 251–259. 27 indexed citations
9.
Trail, Pamela A., David Willner, Shirley J. Lasch, et al.. (1993). Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates. Science. 261(5118). 212–215. 414 indexed citations
10.
Willner, David, Pamela A. Trail, Sandra J. Hofstead, et al.. (1993). (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjugate Chemistry. 4(6). 521–527. 183 indexed citations
11.
Leet, John E., Daniel R. Schroeder, David R. Langley, et al.. (1993). Chemistry and structure elucidation of the kedarcidin chromophore. Journal of the American Chemical Society. 115(18). 8432–8443. 87 indexed citations
12.
Hofstead, Sandra J., James A. Matson, Alison R. Malacko, & Hans Marquardt. (1992). Kedarcidin, a new chromoprotein antitumor antibiotic. II. Isolation, purification and physico-chemical properties.. The Journal of Antibiotics. 45(8). 1250–1254. 53 indexed citations
13.
Leet, John E., Jerzy Golik, Sandra J. Hofstead, et al.. (1992). Kedarcidin chromophore: Structure elucidation of the amino sugar kedarosamine. Tetrahedron Letters. 33(41). 6107–6110. 17 indexed citations
14.
Leet, John E., Daniel R. Schroeder, Sandra J. Hofstead, et al.. (1992). Kedarcidin, a new chromoprotein antitumor antibiotic: structure elucidation of kedarcidin chromophore. Journal of the American Chemical Society. 114(20). 7946–7948. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026